Stocks to Watch: NewLink Genetics Corporation (NASDAQ:NLNK), Blue Capital Reinsurance Holdings Ltd.

NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including both cellular immunotherapy and checkpoint inhibitor platforms, will release its fourth quarter and year end 2015 financial results on Monday, February 29, 2016.

NewLink Genetics Corporation (NASDAQ:NLNK) belongs to Healthcare sector. Its net profit margin is 47.00% and weekly performance is -3.79%. On last trading day company shares ended up at $21.35.

Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) Board of Directors has declared a special dividend of $1.24 per common share, which is payable on March 15, 2016 to all shareholders of record as of February 29, 2016.

Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) shares moved up 0.10% in last trading session and ended the day at $19.23. BCRH return on assets is 9.50%. Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) quarterly performance is 8.64%.

Digirad Corporation (NASDAQ:DRAD) will release financial results for its fourth quarter and year ended December 31, 2015, before the market opens on Friday, February 26, 2016.

On 23 February, Digirad Corporation (NASDAQ:DRAD) shares moved up 0.85% and was closed at $4.76. DRAD EPS growth in last 5 year was 34.10%. Digirad Corporation (NASDAQ:DRAD) year to date (YTD) performance is -17.79%.

Core Laboratories (NYSE:CLB) had its price target cut by ING Group from $125.00 to $112.00 in a research note published on Wednesday, StockTargetPrices.com reports. They currently have a hold rating on the stock.

Core Laboratories NV (NYSE:CLB) ended the last trading day at $103.07. Company weekly volatility is calculated as 4.80% and price to cash ratio as 194.14. Core Laboratories NV (NYSE:CLB) showed a weekly performance of 1.38%.

InfuSystem Holdings, Inc. (NYSEMKT:INFU) shares moved up 0.96% in last trading session and ended the day at $3.16. INFU Gross Margin is 70.90% and its return on assets is 3.20%. InfuSystem Holdings, Inc. (NYSEMKT:INFU) quarterly performance is 11.27%.

Leave a Reply

Your email address will not be published. Required fields are marked *